CRH Medical (CRHM) Misses Q3 EPS by 4c

CRH Medical (NYSE: CRHM) reported Q3 revenue of $30.4 million versus the consensus estimate of $27.81 million.

• Total revenue of $30.4 million, up 5.9% from third quarter 2018
• Anesthesia services revenue of $28.0 million, up 7.3% from third quarter 2018
• Adjusted operating EBITDA of $13.1 million, a 42.9% adjusted operating EBITDA margin
• Adjusted operating shareholder EBITDA: $9.4 million, up 10.3% from third quarter 2018
• Anesthesia patient cases of 88,733, increased 23.6% from third quarter 2018
• The purchase of CRH's remaining interest in Central Colorado Anesthesia Associates, LLC
• The acquisition of a 51% interest in Crystal River Anesthesia Associates, LLC

Tushar Ramani, Chief Executive Officer of CRH commented, "We continued to produce solid financial results in the third quarter. We completed two transactions during the quarter and have an increasing number of deals pending closing or in the final stages of negotiation. Our recently announced credit facility provides us with an expanded flexibility to support our business strategy, and our team remains focused on positioning CRH to benefit from the favorable long-term fundamentals present across both of our business segments."

For earnings history and earnings-related data on CRH Medical (CRHM) click here.

You May Also Be Interested In

• Growth isn't weak enough to truly undercut inflation pressures - BMO
• Warren Buffet's Berkshire stock target raised at UBS into earnings
• PayPal (PYPL) stock: Risk-reward 'finally looks favorable' says Deutsche Bank